Red blood cell alloimmunization after blood transfusion /:
"An investigation of the safety implications of pre-transfusion policy which requires the patient''s serum to be tested for the presence of irregular red blood cell antibodies"--EBL.
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Leiden :
Leiden University Press,
2008.
|
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | "An investigation of the safety implications of pre-transfusion policy which requires the patient''s serum to be tested for the presence of irregular red blood cell antibodies"--EBL. |
Beschreibung: | 1 online resource (176 pages) : illustrations |
Bibliographie: | Includes bibliographical references. |
ISBN: | 9789048502172 9048502179 9087280319 9789087280314 1282387359 9781282387355 9786612387357 6612387351 |
Internformat
MARC
LEADER | 00000cam a2200000Ma 4500 | ||
---|---|---|---|
001 | ZDB-4-EBA-ocn646885623 | ||
003 | OCoLC | ||
005 | 20241004212047.0 | ||
006 | m o d | ||
007 | cr cn||||||||| | ||
008 | 080204s2008 ne a ob 000 0 eng d | ||
040 | |a E7B |b eng |e pn |c E7B |d OCLCQ |d N$T |d EBLCP |d IDEBK |d OCLCQ |d YBM |d OCLCF |d OCLCQ |d OCLCO |d OCLCQ |d LOA |d AGLDB |d Z5A |d MOR |d PIFAG |d OCLCQ |d U3W |d STF |d WRM |d OCLCQ |d VTS |d COCUF |d NRAMU |d VT2 |d OCLCQ |d WYU |d OCLCA |d OCLCQ |d AJS |d QGK |d OCLCO |d OCLCQ |d OCLCO |d OCLCL | ||
019 | |a 489040274 |a 764529397 |a 961637294 |a 962697523 |a 966233483 |a 988486448 |a 992065603 |a 1037938737 |a 1038563561 |a 1045487781 |a 1055403895 |a 1058972029 |a 1081288167 |a 1097105686 |a 1228546962 |a 1259214973 | ||
020 | |a 9789048502172 |q (electronic bk.) | ||
020 | |a 9048502179 |q (electronic bk.) | ||
020 | |a 9087280319 | ||
020 | |a 9789087280314 | ||
020 | |z 9789087280314 | ||
020 | |a 1282387359 | ||
020 | |a 9781282387355 | ||
020 | |a 9786612387357 | ||
020 | |a 6612387351 | ||
035 | |a (OCoLC)646885623 |z (OCoLC)489040274 |z (OCoLC)764529397 |z (OCoLC)961637294 |z (OCoLC)962697523 |z (OCoLC)966233483 |z (OCoLC)988486448 |z (OCoLC)992065603 |z (OCoLC)1037938737 |z (OCoLC)1038563561 |z (OCoLC)1045487781 |z (OCoLC)1055403895 |z (OCoLC)1058972029 |z (OCoLC)1081288167 |z (OCoLC)1097105686 |z (OCoLC)1228546962 |z (OCoLC)1259214973 | ||
041 | 0 | |a eng |b dut | |
043 | |a e-ne--- | ||
050 | 4 | |a RM171 |b .S36 2008eb | |
072 | 7 | |a MED |x 071000 |2 bisacsh | |
082 | 7 | |a 615/.39 |2 22 | |
049 | |a MAIN | ||
100 | 1 | |a Schonewille, Henk, |d 1959- | |
245 | 1 | 0 | |a Red blood cell alloimmunization after blood transfusion / |c Henk Schonewille. |
260 | |a Leiden : |b Leiden University Press, |c 2008. | ||
300 | |a 1 online resource (176 pages) : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
504 | |a Includes bibliographical references. | ||
505 | 0 | |a Review of the Literature on red Cell Alloimmunization -- Alloimmunization to red Blood Cell Antigens after Universal Leucodepletion. A regional multicentre retrospective study -- The importance of antibodies against loq-incidence RBC Antigens in complete and abbreviated cross-matching -- Alloimmunization after blood transfusion in patients with hametologic and oncologic diseases -- Additional RBC alloantibodies after blood transfusion in a nonhematological alloimmunizaed patient cohort: is it time to take precautionary measures? -- High additional maternal red cell alloimmuzation after RH- and K-Matched intrautertine intravascular transfusions for homolytic disease of the fetus 8. RBC antibody persistence -- Red vlood cell alloantibodies after transfusion: Factors influencing incidence and specificity. | |
546 | |a Text in English and Dutch. | ||
588 | 0 | |a Print version record. | |
520 | |a "An investigation of the safety implications of pre-transfusion policy which requires the patient''s serum to be tested for the presence of irregular red blood cell antibodies"--EBL. | ||
650 | 0 | |a Blood |x Transfusion |x Safety measures. | |
650 | 0 | |a Blood |x Transfusion |z Netherlands. | |
650 | 6 | |a Sang |x Transfusion |x Sécurité |x Mesures. | |
650 | 6 | |a Sang |x Transfusion |z Pays-Bas. | |
650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
650 | 7 | |a Blood |x Transfusion |2 fast | |
650 | 7 | |a Blood |x Transfusion |x Safety measures |2 fast | |
651 | 7 | |a Netherlands |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJk4D96j3YTHJQfHCV3vpP | |
758 | |i has work: |a Red blood cell alloimmunization after blood transfusion (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGKjj87XvTrgqQXvV8Fgw3 |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
776 | 0 | 8 | |i Print version: |a Schonewille, Henk. |t Red blood cell alloimmunization after blood transfusion. |d [Leiden] : Leiden University Press, ©2008 |z 9789087280314 |
856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=298518 |3 Volltext |
938 | |a ProQuest Ebook Central |b EBLB |n EBL474320 | ||
938 | |a ebrary |b EBRY |n ebr10354071 | ||
938 | |a EBSCOhost |b EBSC |n 298518 | ||
994 | |a 92 |b GEBAY | ||
912 | |a ZDB-4-EBA | ||
049 | |a DE-863 |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-4-EBA-ocn646885623 |
---|---|
_version_ | 1816881727217336320 |
adam_text | |
any_adam_object | |
author | Schonewille, Henk, 1959- |
author_facet | Schonewille, Henk, 1959- |
author_role | |
author_sort | Schonewille, Henk, 1959- |
author_variant | h s hs |
building | Verbundindex |
bvnumber | localFWS |
callnumber-first | R - Medicine |
callnumber-label | RM171 |
callnumber-raw | RM171 .S36 2008eb |
callnumber-search | RM171 .S36 2008eb |
callnumber-sort | RM 3171 S36 42008EB |
callnumber-subject | RM - Therapeutics and Pharmacology |
collection | ZDB-4-EBA |
contents | Review of the Literature on red Cell Alloimmunization -- Alloimmunization to red Blood Cell Antigens after Universal Leucodepletion. A regional multicentre retrospective study -- The importance of antibodies against loq-incidence RBC Antigens in complete and abbreviated cross-matching -- Alloimmunization after blood transfusion in patients with hametologic and oncologic diseases -- Additional RBC alloantibodies after blood transfusion in a nonhematological alloimmunizaed patient cohort: is it time to take precautionary measures? -- High additional maternal red cell alloimmuzation after RH- and K-Matched intrautertine intravascular transfusions for homolytic disease of the fetus 8. RBC antibody persistence -- Red vlood cell alloantibodies after transfusion: Factors influencing incidence and specificity. |
ctrlnum | (OCoLC)646885623 |
dewey-full | 615/.39 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.39 |
dewey-search | 615/.39 |
dewey-sort | 3615 239 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04073cam a2200637Ma 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn646885623</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">080204s2008 ne a ob 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">E7B</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">E7B</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">N$T</subfield><subfield code="d">EBLCP</subfield><subfield code="d">IDEBK</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YBM</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">LOA</subfield><subfield code="d">AGLDB</subfield><subfield code="d">Z5A</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFAG</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">U3W</subfield><subfield code="d">STF</subfield><subfield code="d">WRM</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">COCUF</subfield><subfield code="d">NRAMU</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AJS</subfield><subfield code="d">QGK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">489040274</subfield><subfield code="a">764529397</subfield><subfield code="a">961637294</subfield><subfield code="a">962697523</subfield><subfield code="a">966233483</subfield><subfield code="a">988486448</subfield><subfield code="a">992065603</subfield><subfield code="a">1037938737</subfield><subfield code="a">1038563561</subfield><subfield code="a">1045487781</subfield><subfield code="a">1055403895</subfield><subfield code="a">1058972029</subfield><subfield code="a">1081288167</subfield><subfield code="a">1097105686</subfield><subfield code="a">1228546962</subfield><subfield code="a">1259214973</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789048502172</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9048502179</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9087280319</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789087280314</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9789087280314</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1282387359</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781282387355</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786612387357</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6612387351</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)646885623</subfield><subfield code="z">(OCoLC)489040274</subfield><subfield code="z">(OCoLC)764529397</subfield><subfield code="z">(OCoLC)961637294</subfield><subfield code="z">(OCoLC)962697523</subfield><subfield code="z">(OCoLC)966233483</subfield><subfield code="z">(OCoLC)988486448</subfield><subfield code="z">(OCoLC)992065603</subfield><subfield code="z">(OCoLC)1037938737</subfield><subfield code="z">(OCoLC)1038563561</subfield><subfield code="z">(OCoLC)1045487781</subfield><subfield code="z">(OCoLC)1055403895</subfield><subfield code="z">(OCoLC)1058972029</subfield><subfield code="z">(OCoLC)1081288167</subfield><subfield code="z">(OCoLC)1097105686</subfield><subfield code="z">(OCoLC)1228546962</subfield><subfield code="z">(OCoLC)1259214973</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield><subfield code="b">dut</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">e-ne---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM171</subfield><subfield code="b">.S36 2008eb</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">071000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615/.39</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schonewille, Henk,</subfield><subfield code="d">1959-</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Red blood cell alloimmunization after blood transfusion /</subfield><subfield code="c">Henk Schonewille.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Leiden :</subfield><subfield code="b">Leiden University Press,</subfield><subfield code="c">2008.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (176 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Review of the Literature on red Cell Alloimmunization -- Alloimmunization to red Blood Cell Antigens after Universal Leucodepletion. A regional multicentre retrospective study -- The importance of antibodies against loq-incidence RBC Antigens in complete and abbreviated cross-matching -- Alloimmunization after blood transfusion in patients with hametologic and oncologic diseases -- Additional RBC alloantibodies after blood transfusion in a nonhematological alloimmunizaed patient cohort: is it time to take precautionary measures? -- High additional maternal red cell alloimmuzation after RH- and K-Matched intrautertine intravascular transfusions for homolytic disease of the fetus 8. RBC antibody persistence -- Red vlood cell alloantibodies after transfusion: Factors influencing incidence and specificity.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">Text in English and Dutch.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"An investigation of the safety implications of pre-transfusion policy which requires the patient''s serum to be tested for the presence of irregular red blood cell antibodies"--EBL.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Blood</subfield><subfield code="x">Transfusion</subfield><subfield code="x">Safety measures.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Blood</subfield><subfield code="x">Transfusion</subfield><subfield code="z">Netherlands.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Sang</subfield><subfield code="x">Transfusion</subfield><subfield code="x">Sécurité</subfield><subfield code="x">Mesures.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Sang</subfield><subfield code="x">Transfusion</subfield><subfield code="z">Pays-Bas.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Blood</subfield><subfield code="x">Transfusion</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Blood</subfield><subfield code="x">Transfusion</subfield><subfield code="x">Safety measures</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Netherlands</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJk4D96j3YTHJQfHCV3vpP</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Red blood cell alloimmunization after blood transfusion (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGKjj87XvTrgqQXvV8Fgw3</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Schonewille, Henk.</subfield><subfield code="t">Red blood cell alloimmunization after blood transfusion.</subfield><subfield code="d">[Leiden] : Leiden University Press, ©2008</subfield><subfield code="z">9789087280314</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=298518</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL474320</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10354071</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">298518</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
geographic | Netherlands fast https://id.oclc.org/worldcat/entity/E39PBJk4D96j3YTHJQfHCV3vpP |
geographic_facet | Netherlands |
id | ZDB-4-EBA-ocn646885623 |
illustrated | Illustrated |
indexdate | 2024-11-27T13:17:19Z |
institution | BVB |
isbn | 9789048502172 9048502179 9087280319 9789087280314 1282387359 9781282387355 9786612387357 6612387351 |
language | English |
oclc_num | 646885623 |
open_access_boolean | |
owner | MAIN DE-863 DE-BY-FWS |
owner_facet | MAIN DE-863 DE-BY-FWS |
physical | 1 online resource (176 pages) : illustrations |
psigel | ZDB-4-EBA |
publishDate | 2008 |
publishDateSearch | 2008 |
publishDateSort | 2008 |
publisher | Leiden University Press, |
record_format | marc |
spelling | Schonewille, Henk, 1959- Red blood cell alloimmunization after blood transfusion / Henk Schonewille. Leiden : Leiden University Press, 2008. 1 online resource (176 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references. Review of the Literature on red Cell Alloimmunization -- Alloimmunization to red Blood Cell Antigens after Universal Leucodepletion. A regional multicentre retrospective study -- The importance of antibodies against loq-incidence RBC Antigens in complete and abbreviated cross-matching -- Alloimmunization after blood transfusion in patients with hametologic and oncologic diseases -- Additional RBC alloantibodies after blood transfusion in a nonhematological alloimmunizaed patient cohort: is it time to take precautionary measures? -- High additional maternal red cell alloimmuzation after RH- and K-Matched intrautertine intravascular transfusions for homolytic disease of the fetus 8. RBC antibody persistence -- Red vlood cell alloantibodies after transfusion: Factors influencing incidence and specificity. Text in English and Dutch. Print version record. "An investigation of the safety implications of pre-transfusion policy which requires the patient''s serum to be tested for the presence of irregular red blood cell antibodies"--EBL. Blood Transfusion Safety measures. Blood Transfusion Netherlands. Sang Transfusion Sécurité Mesures. Sang Transfusion Pays-Bas. MEDICAL Pharmacology. bisacsh Blood Transfusion fast Blood Transfusion Safety measures fast Netherlands fast https://id.oclc.org/worldcat/entity/E39PBJk4D96j3YTHJQfHCV3vpP has work: Red blood cell alloimmunization after blood transfusion (Text) https://id.oclc.org/worldcat/entity/E39PCGKjj87XvTrgqQXvV8Fgw3 https://id.oclc.org/worldcat/ontology/hasWork Print version: Schonewille, Henk. Red blood cell alloimmunization after blood transfusion. [Leiden] : Leiden University Press, ©2008 9789087280314 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=298518 Volltext |
spellingShingle | Schonewille, Henk, 1959- Red blood cell alloimmunization after blood transfusion / Review of the Literature on red Cell Alloimmunization -- Alloimmunization to red Blood Cell Antigens after Universal Leucodepletion. A regional multicentre retrospective study -- The importance of antibodies against loq-incidence RBC Antigens in complete and abbreviated cross-matching -- Alloimmunization after blood transfusion in patients with hametologic and oncologic diseases -- Additional RBC alloantibodies after blood transfusion in a nonhematological alloimmunizaed patient cohort: is it time to take precautionary measures? -- High additional maternal red cell alloimmuzation after RH- and K-Matched intrautertine intravascular transfusions for homolytic disease of the fetus 8. RBC antibody persistence -- Red vlood cell alloantibodies after transfusion: Factors influencing incidence and specificity. Blood Transfusion Safety measures. Blood Transfusion Netherlands. Sang Transfusion Sécurité Mesures. Sang Transfusion Pays-Bas. MEDICAL Pharmacology. bisacsh Blood Transfusion fast Blood Transfusion Safety measures fast |
title | Red blood cell alloimmunization after blood transfusion / |
title_auth | Red blood cell alloimmunization after blood transfusion / |
title_exact_search | Red blood cell alloimmunization after blood transfusion / |
title_full | Red blood cell alloimmunization after blood transfusion / Henk Schonewille. |
title_fullStr | Red blood cell alloimmunization after blood transfusion / Henk Schonewille. |
title_full_unstemmed | Red blood cell alloimmunization after blood transfusion / Henk Schonewille. |
title_short | Red blood cell alloimmunization after blood transfusion / |
title_sort | red blood cell alloimmunization after blood transfusion |
topic | Blood Transfusion Safety measures. Blood Transfusion Netherlands. Sang Transfusion Sécurité Mesures. Sang Transfusion Pays-Bas. MEDICAL Pharmacology. bisacsh Blood Transfusion fast Blood Transfusion Safety measures fast |
topic_facet | Blood Transfusion Safety measures. Blood Transfusion Netherlands. Sang Transfusion Sécurité Mesures. Sang Transfusion Pays-Bas. MEDICAL Pharmacology. Blood Transfusion Blood Transfusion Safety measures Netherlands |
url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=298518 |
work_keys_str_mv | AT schonewillehenk redbloodcellalloimmunizationafterbloodtransfusion |